ziprasidone hydrochloride

Generic: ziprasidone hydrochloride

Labeler: macleods pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ziprasidone hydrochloride
Generic Name ziprasidone hydrochloride
Labeler macleods pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ziprasidone hydrochloride 40 mg/1

Manufacturer
Macleods Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 33342-145
Product ID 33342-145_a28d3d06-0479-4c6a-9e92-34b4ef776ac2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204375
Listing Expiration 2026-12-31
Marketing Start 2017-02-18

Pharmacologic Class

Classes
atypical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 33342145
Hyphenated Format 33342-145

Supplemental Identifiers

RxCUI
313776 313777 313778 314286
UPC
0333342144515 0333342146090 0333342145093 0333342145512 0333342147097 0333342147516 0333342146519
UNII
216X081ORU

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ziprasidone hydrochloride (source: ndc)
Generic Name ziprasidone hydrochloride (source: ndc)
Application Number ANDA204375 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (33342-145-09)
  • 10 BLISTER PACK in 1 CARTON (33342-145-12) / 10 CAPSULE in 1 BLISTER PACK
  • 300 CAPSULE in 1 BOTTLE (33342-145-51)
source: ndc

Packages (3)

33342-145-09 60 CAPSULE in 1 BOTTLE (33342-145-09) 33342-145-12 10 BLISTER PACK in 1 CARTON (33342-145-12) / 10 CAPSULE in 1 BLISTER PACK 33342-145-51 300 CAPSULE in 1 BOTTLE (33342-145-51)

Ingredients (1)

ziprasidone hydrochloride (40 mg/1)

Linked Drug Pages (1)

Ziprasidone Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a28d3d06-0479-4c6a-9e92-34b4ef776ac2", "openfda": {"upc": ["0333342144515", "0333342146090", "0333342145093", "0333342145512", "0333342147097", "0333342147516", "0333342146519"], "unii": ["216X081ORU"], "rxcui": ["313776", "313777", "313778", "314286"], "spl_set_id": ["3e0d1436-2e2b-4c34-a9bc-4a6b2ac38af0"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (33342-145-09)", "package_ndc": "33342-145-09", "marketing_start_date": "20170218"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (33342-145-12)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "33342-145-12", "marketing_start_date": "20170218"}, {"sample": false, "description": "300 CAPSULE in 1 BOTTLE (33342-145-51)", "package_ndc": "33342-145-51", "marketing_start_date": "20170218"}], "brand_name": "Ziprasidone Hydrochloride", "product_id": "33342-145_a28d3d06-0479-4c6a-9e92-34b4ef776ac2", "dosage_form": "CAPSULE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "33342-145", "generic_name": "Ziprasidone Hydrochloride", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ziprasidone Hydrochloride", "active_ingredients": [{"name": "ZIPRASIDONE HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "ANDA204375", "marketing_category": "ANDA", "marketing_start_date": "20170218", "listing_expiration_date": "20261231"}